Trean Insurance Group Inc TIG 深 滬
等待開盤 10-28 09:30:00 美东时间
6.16
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 6.16
- 總市值 3.16亿
- 52周最高 7.34
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 2.12
- 委 比 0.00%
- 總股本 5123.82万
- 歷史最高 41.98
- 量 比 0
- 振 幅 0.00%
- 歷史最低 2.12
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025
HOLON, Israel, Oct. 27, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target di...
10-27 19:00
奇瑞获颁TÜV南德宠物友好型材料认证
TÜV南德向奇瑞颁发宠物友好型材料认证证书，确认奇瑞TIGGO9汽车搭载的环保科技精英织物和皮革内饰符合TÜV南德宠物友好型材料认证要求。（美通社）
10-27 15:12
TROPION-PanTumor03 Phase 2 Trial Shows That DATROWAY, Jointly Developed And Commercialized By Daiichi Sankyo And AstraZeneca, Reveals Promising Tumor Responses in Patients with Metastatic Urothelial Cancer in TROPION-PanTumor03 Phase 2 Trial; A Confirmed Objective Response Rate Of 68.2% And A Disease Control Rate Of 95.5% Was Observed In Previously Untreated, Cisplatin Ineligible Patients
Initial results from one sub-study of the TROPION-PanTumor03 phase 2 trial showed that DATROWAY® (datopotamab deruxtecan) plus rilvegostomig showed promising tumor responses and disease control as first-line and
10-17 22:13
阿斯利康携四项重磅研究首发数据亮相ESMO，彰显重新定义癌症治疗的雄心
（来源：氨基观察） DESTINY-Breast11与DESTINY-Breast05两项研究入选主席研讨会（Presidential Symposium）...
10-15 12:05
泽璟制药2025中报：商业化进程显著提速，创新研发持续突破，迈向盈利拐点
（来源：财评社） 出品 | 财评社 文章 | 宝剑 编辑 | 笔谈 泽璟制药正稳步迈向盈亏平衡的关键拐点。 2025年上半年，泽璟制药（688266...
10-12 06:17
聚变领域重量级突破！上海电气交付全球最大TF线圈盒
10月7日，由上海电气和中国科学院等离子体物理研究所（以下简称“等离子体所”）联合研制的国家“十三五”重大科技基础设施——“聚变堆主机关键系统综合研究设施（C...
10-10 08:14
Johnson & Johnson Unveils Data Showing ACUVUE OASYS MAX 1-Day For Astigmatism Outperforms Competitor, Expands Multifocal Options For Presbyopic Patients
Studies presented at #Academy25 reveal that ACUVUE OASYS MAX 1-Day for ASTIGMATISM outperformed Dailies Total1® for Astigmatism in patient reported outcomes related to vision and comfort.Research highlights
10-07 20:09
Compugen to Present at SITC 2025
HOLON, Israel, Oct. 6, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...
10-06 19:00
Metal Powder Works Completes Reverse Acquisition and Adjusts Financials
An update from K-TIG Ltd ( ($AU:MPW) ) is now available. Metal Powder Works Lim...
09-29 07:58
9月26日隔夜要闻：美国第二季度经济增速大幅上修 美联储官员称或需进一步降息 美国二手房成交量小幅下滑
专题：四季度A股怎么走？机构研判：震荡偏强慢牛可期 欲览更多环球财经资讯，请移步7×24小时实时财经新闻 市场 ...
09-26 06:49
